tykhr
sign in
free sign up
Tekla Life Sciences Investors
Asset Management
Financial Services
HQL
28.87 M shares
NYSE US
traded
23 Sep 2025
listed
no
open
14.06
52 week high
15.01
high
14.15
52 week low
0.00
low
14.06
growth
-6.00 %
previous Close
14.12
P/E ratio
-9
market cap
413 M
div yield
0
usd
Mar 2025
qoq
revenue
18.20 M
850.46 %
net incoming
-47.23 M
-234.80 %
eps
-1.64 %
-234.43 %
eps surprise
0.00 %
net profit margin
-259.55 %
-2089.00 %
operating incoming
-47.23 M
-3.00 %
net change in cash
0.00 %
cash on hand
0.00 %
cost of revenue
2.53 M
-10.58 %
top